Reviews in Clinical Medicine (Sep 2021)

Evaluation of Interleukin 33 and ST2 Serum Concentration in Active Tuberculosis Patients

  • Masoud Youssefi,
  • Golsa Teimouri,
  • Farnaz Zahedi Avval,
  • kiarash ghazvini,
  • Masoud Keikha

DOI
https://doi.org/10.22038/rcm.2021.59643.1373
Journal volume & issue
Vol. 8, no. 3
pp. 106 – 110

Abstract

Read online

The aim of this study was to determine the serum levels of ST2 protein and interleukin-33 in patients affected to tuberculosis and compare them with the control group. In the present study, at first 30 patients affected to TB were randomly selected and 52 healthy individuals, who were matched with respect to their age and gender, included in the study as the control group. After that, the serum levels of sST2 and IL33 were measured by ELISA sandwich method using commercial Quantikine Human ELISA kit (R&D Systems). The data were finally analyzed by SPSS software. IL-33 levels in the TB group were higher than the healthy controls and a statistically significant difference was observed in the IL-33 levels between the two groups (P = 0.021). Moreover, IL-33R (ST2) was slightly increased in the TB patients compared to the healthy controls, although statistical analysis showed no significant difference between the two groups (P = 0.083). Regarding the high normal variation of sST2 and the limitations of the present study, it is recommended that future studies of sST2 be performed in with higher number of TB patients.

Keywords